Pharma Nasir SRL
Pharma Nasir reported total assets of 126,608 € at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Jun 2026).
The score of Pharma Nasir shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +34 % Total assets -25 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Nasir's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jun 2026
- Year ended 31 Dec 2024filed on 06 Aug 2025
- Year ended 31 Dec 2023filed on 16 Jul 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 13 Jul 2022
Pharma Nasir's financial analysis
- Solvency67.4%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Nasir
Pharma Nasir's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0651.586.018
- VAT number
- BE0651586018
- Peppol
- Registered · 0208:0651586018 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Apr 2016
- Registered office
- 1050 Ixelles
- Latest accounts
- 2025 · filed on 09 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharma Nasir (SRL) has been based in Ixelles since 2016, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 2,519 € and equity of 85,307 €; its revenue is not published. Its solvency stands at 67.4%, above the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharma Nasir
Companies in the same business, of comparable size and area, outside its group.
- Grodt Retail sale of pharmaceutical products Uccle · balance sheet 109,794 €
- Pharmacie VERHEYDEN Retail sale of pharmaceutical products Brussels · balance sheet 135,673 €
- Sirona Retail sale of pharmaceutical products Etterbeek · balance sheet 126,289 €
- Mont Royal Retail sale of pharmaceutical products Brussels · balance sheet 126,135 €
- O.Sabur Retail sale of pharmaceutical products Genk · balance sheet 129,423 €
- Apotheker Kaat Stas Retail sale of pharmaceutical products Mortsel · balance sheet 123,434 €
- Medlinx Lina Retail sale of pharmaceutical products Schaerbeek · balance sheet 130,245 €
- Toelen Apotekers Retail sale of pharmaceutical products Halle · balance sheet 118,845 €
Frequently asked questions about Pharma Nasir
What is the revenue of Pharma Nasir?
Pharma Nasir files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Nasir?
In Belgium, the VAT number is the company number prefixed with BE: BE0651586018 for Pharma Nasir, if the company is VAT-registered. Its company number (CBE) is 0651.586.018.
Where is the registered office of Pharma Nasir?
According to the CBE register, the registered office of Pharma Nasir is in 1050 Ixelles.
What is the equity of Pharma Nasir?
At the close of the 2025 financial year, the equity of Pharma Nasir amounts to 85,307 €, a solvency of 67.4% of total assets.
Who manages Pharma Nasir?
The register lists 1 active mandates at Pharma Nasir. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Nasir
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →